Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Proto Labs (PRLB) EBITDA (2016 - 2025)

Proto Labs (PRLB) has disclosed EBITDA for 15 consecutive years, with $9.7 million as the latest value for Q4 2025.

  • Quarterly EBITDA rose 734.57% to $9.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $28.2 million through Dec 2025, up 69.95% year-over-year, with the annual reading at $28.2 million for FY2025, 69.95% up from the prior year.
  • EBITDA hit $9.7 million in Q4 2025 for Proto Labs, up from $7.1 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $14.9 million in Q2 2021 to a low of -$102.4 million in Q4 2022.
  • Historically, EBITDA has averaged -$1.6 million across 5 years, with a median of $4.2 million in 2024.
  • Biggest five-year swings in EBITDA: plummeted 1297.47% in 2022 and later surged 995.67% in 2023.
  • Year by year, EBITDA stood at $8.6 million in 2021, then tumbled by 1297.47% to -$102.4 million in 2022, then soared by 109.05% to $9.3 million in 2023, then tumbled by 116.58% to -$1.5 million in 2024, then surged by 734.57% to $9.7 million in 2025.
  • Business Quant data shows EBITDA for PRLB at $9.7 million in Q4 2025, $7.1 million in Q3 2025, and $6.8 million in Q2 2025.